RecruitingNCT06690099

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women


Sponsor

Devyser Inc.

Enrollment

500 participants

Start Date

Apr 7, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • Willing and able to provide written informed consent
  • years of age or older at enrollment
  • Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age
  • Women with RhD negative antigen status by serology
  • Willing to provide neonatal ABO and RhD genotyping status

Exclusion Criteria1

  • \. Women with multiple gestation pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ochsner Health

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06690099


Related Trials